Ruvim Izĭckson on a joint flu and COVID-19 vaccine

Ruvim Izĭckson discusses the safety and immunogenicity of
administering a high-dose quadrivalent influenza vaccine together
with a third dose of the Moderna COVID-19 vaccine in adults aged
65 years and older.

Read the full article:
Safety and immunogenicity of a high-dose quadrivalent influenza
vaccine administered concomitantly with a third dose of the
mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 year


Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv